1. Home
  2. LSTA vs MBBC Comparison

LSTA vs MBBC Comparison

Compare LSTA & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • MBBC
  • Stock Information
  • Founded
  • LSTA 1980
  • MBBC 1902
  • Country
  • LSTA United States
  • MBBC United States
  • Employees
  • LSTA N/A
  • MBBC N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • MBBC Banks
  • Sector
  • LSTA Health Care
  • MBBC Finance
  • Exchange
  • LSTA Nasdaq
  • MBBC Nasdaq
  • Market Cap
  • LSTA 20.0M
  • MBBC 22.1M
  • IPO Year
  • LSTA N/A
  • MBBC N/A
  • Fundamental
  • Price
  • LSTA $2.18
  • MBBC $10.02
  • Analyst Decision
  • LSTA Strong Buy
  • MBBC
  • Analyst Count
  • LSTA 1
  • MBBC 0
  • Target Price
  • LSTA $15.00
  • MBBC N/A
  • AVG Volume (30 Days)
  • LSTA 10.9K
  • MBBC 15.2K
  • Earning Date
  • LSTA 05-08-2025
  • MBBC 05-12-2025
  • Dividend Yield
  • LSTA N/A
  • MBBC N/A
  • EPS Growth
  • LSTA N/A
  • MBBC N/A
  • EPS
  • LSTA N/A
  • MBBC N/A
  • Revenue
  • LSTA $1,000,000.00
  • MBBC $6,554,694.00
  • Revenue This Year
  • LSTA N/A
  • MBBC N/A
  • Revenue Next Year
  • LSTA N/A
  • MBBC N/A
  • P/E Ratio
  • LSTA N/A
  • MBBC N/A
  • Revenue Growth
  • LSTA N/A
  • MBBC N/A
  • 52 Week Low
  • LSTA $1.87
  • MBBC $5.83
  • 52 Week High
  • LSTA $4.20
  • MBBC $12.00
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 44.79
  • MBBC N/A
  • Support Level
  • LSTA $2.07
  • MBBC N/A
  • Resistance Level
  • LSTA $2.46
  • MBBC N/A
  • Average True Range (ATR)
  • LSTA 0.17
  • MBBC 0.00
  • MACD
  • LSTA -0.02
  • MBBC 0.00
  • Stochastic Oscillator
  • LSTA 22.92
  • MBBC 0.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: